Mon, Nov 24, 2014, 11:37 AM EST - U.S. Markets close in 4 hrs 23 mins

Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

  • jfk123_1 jfk123_1 Sep 25, 2013 11:15 AM Flag

    Important message for all longs and Dr. Vin

    I am only trying to help you guys through information and my experience, which is substantial. I am not here for feelings of credibility or a need to be loved. I call it the way it is.

    Dr. Vin. I respect your very long term focus, I do, even if I question your assumptions and premise which differ from mine. But I would suggest that you refrain from dismissing technical and shorter term analysis from your investment framework. You will only be hurting yourself in the long run. Real pros look at the whole picture, long term, valuation, technical, everything. An understanding of technical can help someone like you very simply in that it can help you lower your cost basis as you accumulate a long term position. It also can help you identify the appropriate exit point when and if your longer term targets are achieved. Remember, a real squeeze causes a huge overshoot to fundamental value, and when the squeeze comes off, stock prices usually drop significantly and then undershoot fundamental value. Understanding the technicals (not just price movement but also share ownership and distribution and short covering mechanics) can help you capture that overshoot beyond your ideal target price/valuation/thesis level, and can keep you from holding on too long and then being forced to sell on the post squeeze undershoot. Don't reply, just think about this and learn.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SNTA
3.19+0.01(+0.31%)11:36 AMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.